Related Experiment Video
Updated: Jun 19, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The DiabetAction program: implementation in community-based settings
Marie-Eve Mathieu1, Martin Brochu, Louise Béliveau
1Department of Kinesiology, University of Montreal, Montréal, Québec, Canada.
Abstract:
Developed for specialists who want to increase the physical activity (PA) level of type 2 diabetic and at-risk individuals, the 10-week DiabetAction program introduced participants to a wide variety of cardiovascular resistance, balance, and flexibility exercises. Thirty-three of 48 individuals completed the intervention in community-based settings, while 25 of 29 participants completed control group evaluations. A significant time effect (p < .05) was measured for leisure PA level, resting systolic and diastolic blood pressure, estimated aerobic capacity, and dynamic balance (nonsignificant group effect; p > .05). The physical functioning domain of quality of life improved in the experimental group, while the vitality domain improved in the control group (significant interactions; p < .05). Follow-ups of the experimental group revealed that they maintained postintervention parameters (leisure PA level, proportion of participants > or = 150 min of PA weekly, estimated aerobic capacity) or improved (mental component summary measure of quality of life). Ninety-four percent of the experimental group was "very" or "extremely" satisfied with the program, and participants perceived improvements in PA level, health, and tiredness postintervention. In conclusion, participants in community-based settings improved on many of the measured parameters and maintained PA practice up to 6 months postintervention. However, since control participants also saw improvements, further controlled studies will be needed.
Related Concept Videos
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Introduction
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...